SVV-001

Seneca Valley virus

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SVV-001, covering 2025-12-17 to 2025-12-17. Get the full timeline:

Most recent: Clinical Trial Update: SVV-001 With Nivolumab and Ipilimumab in Patients With Poorly Differentiated Neuroendocrine Carcinomas (NEC) or Well-Differentiated High-Grade Neuroendocrine Tumors (NET) [Phase 1]

See pricing